Drugs that Target Cellular Signaling Pathways for Breast Cancer Treatment
Numerous molecular targeting agents have been created as a result of the discovery of genetic abnormalities and the investigation of various cellular signalling pathways. These agents can be used as therapeutic targets for a variety of diseases. Many new medications have been become available recently to treat breast cancer. These medications can be used orally or intravenously. These drug delivery techniques reduce toxicity and boost effectiveness. The patients have benefited in numerous ways from these new medications and delivery systems, which have replaced the more time-consuming older ones. They have fewer adverse effects and provide patients with better benefits.
Author (s) Details
Department of Chemistry, Faculty of Physical Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan.
University of North Carolina at Greensboro, Greensboro, NC 27403, USA.
Molecular Immunology Laboratory, Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan.
Northcentral University, San Diego, CA, USA.
Kermanshah University of Medical Sciences, Kermanshah, Iran.
Department of Biotechnology, Persian Gulf Research Institute, Bushehr, 75169, Iran.
View Book :- https://stm.bookpi.org/CPMS-V6/article/view/7686
Keywords – Cellular signaling, breast cancer treatment, genetic mutations